DOXIMITY INC-CLASS A (DOCS) Stock Analyst Ratings
NYSE:DOCS • US26622P1075
24.53 USD
-0.57 (-2.27%)
At close: Feb 27, 2026
24.6 USD
+0.07 (+0.29%)
After Hours: 2/27/2026, 8:04:00 PM
ChartMill assigns a Buy % Consensus number of 80% to DOCS. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 44.25. This target is 80.39% above the current price.
- DOCS was analyzed by 29 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about DOCS.
- In the previous month the buy percentage consensus was at a similar level.
- DOCS was analyzed by 29 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-02-20 | JP Morgan | Maintains | Neutral -> Neutral |
| 2026-02-20 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2026-02-11 | Barclays | Maintains | Overweight -> Overweight |
| 2026-02-10 | Mizuho | Maintains | Neutral -> Neutral |
| 2026-02-09 | Canaccord Genuity | Upgrade | Hold -> Buy |
| 2026-02-09 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2026-02-06 | BTIG | Maintains | Buy -> Buy |
| 2026-02-06 | Needham | Maintains | Buy -> Buy |
| 2026-02-06 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-02-06 | Truist Securities | Maintains | Buy -> Buy |
| 2026-02-06 | JP Morgan | Upgrade | Underweight -> Neutral |
| 2026-02-06 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2026-02-06 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2026-01-20 | Wells Fargo | Upgrade | Equal-Weight -> Overweight |
| 2026-01-08 | Keybanc | Maintains | Overweight -> Overweight |
| 2025-12-15 | Morgan Stanley | Upgrade | Equal-Weight -> Overweight |
| 2025-12-09 | Barclays | Initiate | Overweight |
| 2025-11-21 | Raymond James | Upgrade | Outperform -> Strong Buy |
| 2025-11-13 | BMO Capital | Initiate | Market Perform |
| 2025-11-10 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2025-11-07 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-10-27 | B of A Securities | Upgrade | Neutral -> Buy |
| 2025-10-10 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2025-10-08 | Keybanc | Maintains | Overweight -> Overweight |
| 2025-10-08 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-10-01 | Goldman Sachs | Downgrade | Neutral -> Sell |
| 2025-09-18 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2025-09-11 | Baird | Maintains | Outperform -> Outperform |
| 2025-08-11 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-08-08 | Needham | Maintains | Buy -> Buy |
DOXIMITY INC-CLASS A / DOCS FAQ
What is the price target for DOCS stock?
29 analysts have analysed DOCS and the average price target is 44.25 USD. This implies a price increase of 80.39% is expected in the next year compared to the current price of 24.53.
What is the consensus rating for DOCS stock?
The consensus rating for DOXIMITY INC-CLASS A (DOCS) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.